Endocrinology Medical News about papillary thyroid microcarcinoma;decreased tumor size;thyroid cancer

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

3. Rapid correction of low vitamin D status in nursing home residents

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Increased incidence of papillary thyroid microcarcinoma with decreased tumor size of thyroid cancer
Medical Oncology, 06/12/09

Lin JD - In a study to illustrate change in trends and influence of papillary thyroid microcarcinoma (PTMC) in thyroid cancer, it was found that invasive tumor markers or larger tumor size are useful to predict tumor recurrence or distant metastasis for PTMC.

Methods

This study retrospectively reviewed 30 yrs data compared it with recent publications to illustrate change in trends and influence of PTMC.
Incidental PTMC is usually diagnosed as a postoperative microcarcinoma following thyroidectomy for presumably benign thyroid lesions.
Subtotal thyroidectomy or lobectomy without radioactive iodide treatment is sufficient to treat incidental PTMC.
Aggressive surgical treatment with 131I therapy is indicated for non-incidental PTMC.
Those with PTMC in the absence of extra-thyroid invasion diagnosed by postoperative permanent section received follow-up if they had initially received subtotal thyroidectomy.

Results

In long-term follow-up studies, cancer-specific mortality for PTMC ranged from 0% to 4%.
Most of the mortality cases had distant metastasis at the time of surgery.
The clinical course and therapeutic strategies for the non-incidental PTMC pts depend on the TNM stage at the time of diagnosis.
One-third of PTMC with clinically aggressive behavior cannot be treated as indolent disease.

<< Previous
Impact of androgen deprivation therapy on cardiovascular disease...

Next >>
Impaired glucose-induced glucagon suppression after partial...